Michael Molyneaux

Chief Medical Officer at Sirnaomics, Inc.

Michael Molyneaux

Michael Molyneaux

Chief Medical Officer at Sirnaomics, Inc.

Biography

Dr. Michael Molyneaux, MD MBA, is Chief Medical Officer at Macrocure Ltd.He received his undergraduate degree from the University of Prince Edward Island, an MBA from Washington University in St. Louis, and a doctorate degree from Dalhousie University.

Overview
RelSci Relationships

95

Number of Boards

2

Birthday

1970

Age

50

Relationships
RelSci Relationships are individuals Michael Molyneaux likely has professional access to. A relationship does not necessarily indicate a personal connection.

President-Medical Staff at The Passavant Memorial Area Hospital Association

Relationship likelihood: Strong

Former Vice Chairman at The Passavant Memorial Area Hospital Association

Relationship likelihood: Strong

Member, Board of Directors at The Passavant Memorial Area Hospital Association

Relationship likelihood: Strong

Founder at Sirnaomics, Inc.

Relationship likelihood: Strong

Co-Founder at Sirnaomics, Inc.

Relationship likelihood: Strong

Director at Memorial Health System

Relationship likelihood: Strong

Director at The Passavant Memorial Area Hospital Association

Relationship likelihood: Strong

Director at The Passavant Memorial Area Hospital Association

Relationship likelihood: Strong

Member, Board of Directors at The Passavant Memorial Area Hospital Association

Relationship likelihood: Strong

President at Illinois College

Relationship likelihood: Strong

Paths to Michael Molyneaux
Potential Connections via
Relationship Science
You
Michael Molyneaux
Chief Medical Officer at Sirnaomics, Inc.
Career History
Chief Medical Officer
Current

Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD.

Chief Medical Officer
2013 - 2015

Macrocure Ltd. is a clinical-stage biotechnology company, which engages in the development and commercialization of advanced cell therapy products. Its product, CureXcell, is an advanced wound care therapy that treat such wounds by injecting living human white blood cells that have been activate to facilitate the healing process. The company was founded by David Ben-Ami on January 14, 2008 and is headquartered in Petach Tikva, Israel.

Chief Medical Officer
Prior

Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Its clinical stage programs are DKN-01, which is a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1 and TRX518, which is a monoclonal antibody targeting the glucocorticoid-induced tumor necrosis factor-related receptor, or GITR. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.

Boards & Committees
Transactions
Details Hidden

Sirnaomics, Inc. raised money in a private placement transaction

Details Hidden

Sirnaomics, Inc. raised money in a private placement transaction

Details Hidden

Sirnaomics, Inc. raised money in a private placement transaction

Investments
Details Hidden

Macrocure Ltd. is a clinical-stage biotechnology company, which engages in the development and commercialization of advanced cell therapy products. Its product, CureXcell, is an advanced wound care therapy that treat such wounds by injecting living human white blood cells that have been activate to facilitate the healing process. The company was founded by David Ben-Ami on January 14, 2008 and is headquartered in Petach Tikva, Israel.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Michael Molyneaux. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Michael Molyneaux's profile does not indicate a business or promotional relationship of any kind between RelSci and Michael Molyneaux.